Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Riber Regulatory Filings 2016

Jul 25, 2016

1629_iss_2016-07-25_4817e781-3044-4d15-bcfb-33e35db12108.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Order for research system in Asia

Bezons, July 25th, 2016 – 8:00 am – RIBER, the global molecular beam epitaxy (MBE) specialist, is announcing an order for a research machine in Asia.

RIBER has just sold a Compact 21T research system to a prestigious Asian laboratory. This machine will help expand its research capabilities for III-V structures.

The Compact 21T is derived from Compact 21, one of the market's best performing thin-film deposition research systems. It has been chosen for its high level of flexibility, its reliability and its capacity to produce extremely complex and very high-quality materials on a reproducible basis.

This order, recorded in July, should be delivered in 2016.

ABOUT RIBER:

Riber designs and produces molecular beam epitaxy (MBE) systems as well as evaporation sources and cells for the semiconductor industry. This high-tech equipment is essential for the manufacturing of compound semiconductor materials and new materials that are used in numerous consumer applications, from new information technologies to OLED flat screens and next-generation solar cells.

Riber recorded €12.8 million in revenues for 2015, with 93 employees at the end of 2015. The company is ISO9001 certified. Riber is listed on Euronext Paris (Compartment "C") and is part of the CAC Small, CAC Mid & Small, CAC Technology and CAC T. HARD. & EQ indices. Riber is eligible for SME share-based savings schemes.

ISIN: FR0000075954 - RIB Reuters: RIBE.PA Bloomberg: RIB: FP BPI France-approved innovative company

RIBER François Morizet tel: +33 1 39 96 65 00 [email protected]

CALYPTUS Cyril Combe tel: +33 1 53 65 68 68 [email protected]

www.riber.com